News Archive

News Archive

Article Name

Link

Peter Goldschmidt to succeed Claudio Albrecht as STADA’s CEO

Read article

STADA acquires EMEA rights to global anti-dandruff brand Nizoral from Janssen Pharmaceutica

Read article

Ladival wins 'Best Beach Sun Protection 2017'

Read article

T&R signs licensing agreement with Futura Medical

Read article

T&R acquires Natures Aid Ltd

Read article

T&R licenses K-Y Jelly

Read article

T&R acquires Flexitol

Read article

STADA AG completes acquisition of T&R

Read article

Celebrating 90 years of a British institution

Read article

Derma new business shows steady growth

Read article

Thornton & Ross Ltd acquires the Allens brand

Read article



News

STADA invests $660 Million USD in Takeda’s OTC portfolio in Russia/CIS to become a major player in these branded markets

STADA to acquire a portfolio of approximately 20 selected OTC and prescription pharmaceutical products in Russia, Georgia and CIS countries

Click for more info

STADA to acquire Walmark – a leading Consumer Healthcare company in Central Europe

STADA Arzneimittel AG (‘STADA’ or ‘the Group’) today announces the acquisition of Walmark a.s. (‘Walmark’ or ‘the company’) from Mid Europa Partners for an undisclosed consideration.

Click for more info

Q&A 2019 Pharmacy Show

A Q&A Session with Phoebe Buckley on the 2019 Pharmacy Show

Click for more info

STADA Health Report 2019

More than half of people in UK are optimistic about the future of health

Click for more info

Leading pharmaceutical company invests in seven-figure state-of-the-art facility

Huddersfield pharmaceutical company Thornton & Ross is expanding, with a new seven-figure state-of-the-art facility due to open at the beginning of January.

Click for more info

Thornton & Ross triumphant in industry awards

Huddersfield-based pharmaceutical company Thornton & Ross has received national recognition for six of its products at the national 2019 ‘Most Valuable Product’ (MVP) Awards in pharmacy.

Click for more info

Thornton & Ross launches alternative, cost-effective treatment for osteoporosis in UK

West Yorkshire-based pharmaceutical company Thornton & Ross (T&R) is launching an alternative, cost-effective treatment for osteoporosis.

Click for more info

Thornton & Ross to acquire established GSK Consumer Health brands

Thornton & Ross has expanded its Consumer Health business with a contract to acquire four UK skin care brands, as well as a paediatric cough remedy, from GlaxoSmithKline. Completion of the deal is expected to occur by August 2019.

Click for more info

>> News Archive